Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis

BACKGROUND: Sorafenib might prevent hepatocellular carcinoma (HCC) recurrence caused by the promotion of neoangiogenesis after transarterial chemoembolization (TACE). OBJECTIVES: To evaluate the efficacy and safety of TACE followed by sorafenib for treating advanced HCC. PATIENTS AND METHODS: We ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohki, Takamasa, Sato, Koki, Yamagami, Mari, Ito, Daisaku, Yamada, Tomoharu, Kawanishi, Koki, Kojima, Kentaro, Seki, Michiharu, Toda, Nobuo, Tagawa, Kazumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621710/
https://www.ncbi.nlm.nih.gov/pubmed/26446004
http://dx.doi.org/10.1007/s40261-015-0333-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621710/
https://www.ncbi.nlm.nih.gov/pubmed/26446004
http://dx.doi.org/10.1007/s40261-015-0333-3

Ejemplares similares